Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$1.35B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.12B |
| 3 |
Merck
MRK
|
+$763M |
| 4 |
Starbucks
SBUX
|
+$688M |
| 5 |
TSMC
TSM
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.64B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$719M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$713M |
| 4 |
COL
Rockwell Collins
COL
|
+$610M |
| 5 |
ANDV
Andeavor
ANDV
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Financials | 9.82% |
| 3 | Healthcare | 9.37% |
| 4 | Consumer Discretionary | 7.85% |
| 5 | Energy | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNH
2126
CNH Industrial
CNH
$12.7B
| $13.3M | ﹤0.01% |
1,663,917
-1,051,833
| -39% | -$9.28M |
|
2127
CALL
Autodesk
ADSK
$49.5B
| $13.3M | ﹤0.01% |
103,700
+96,300
| +1,301% | +$13M |
|
2128
CALL
American International
AIG
$41.7B
| $13.3M | ﹤0.01% |
338,400
+39,000
| +13% | +$1.7M |
|
2129
GATX Corp
GATX
$6.35B
| $13.3M | ﹤0.01% |
188,181
-50,895
| -21% | -$4.01M |
|
2130
McGrath RentCorp
MGRC
$2.81B
| $13.3M | ﹤0.01% |
258,569
-38,948
| -13% | -$2M |
|
2131
Kulicke & Soffa
KLIC
$4.67B
| $13.3M | ﹤0.01% |
655,639
-10,896
| -2% | -$226K |
|
2132
Brookdale Senior Living
BKD
$3.49B
| $13.3M | ﹤0.01% |
1,982,758
-895,453
| -31% | -$7.51M |
|
2133
iShares MSCI USA Value Factor ETF
VLUE
$9.17B
| $13.2M | ﹤0.01% |
182,246
+121,353
| +199% | +$9.81M |
|
2134
GameStop
GME
$9.75B
| $13.2M | ﹤0.01% |
4,188,684
-2,547,576
| -38% | -$8.91M |
|
|
DRNA
2135
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13.2M | ﹤0.01% |
1,232,262
-124,522
| -9% | -$1.64M |
|
2136
STMicroelectronics
STM
$46.7B
| $13.1M | ﹤0.01% |
947,075
+230,682
| +32% | +$3.46M |
|
|
CTXS
2137
CALL
DELISTED
Citrix Systems Inc
CTXS
| $13.1M | ﹤0.01% |
128,100
+92,000
| +255% | +$9.72M |
|
|
MDCO
2138
DELISTED
Medicines Co
MDCO
| $13.1M | ﹤0.01% |
684,941
+240,392
| +54% | +$5.59M |
|
|
EVBG
2139
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $13.1M | ﹤0.01% |
230,710
+67,239
| +41% | +$3.49M |
|
2140
Ultragenyx Pharmaceutical
RARE
$2.45B
| $13.1M | ﹤0.01% |
300,867
-3,543
| -1% | -$194K |
|
2141
PUT
Lam Research
LRCX
$367B
| $13.1M | ﹤0.01% |
960,000
+700,000
| +269% | +$10M |
|
|
CNXM
2142
DELISTED
CNX Midstream Partners LP
CNXM
| $13.1M | ﹤0.01% |
802,408
-407,431
| -34% | -$7.37M |
|
2143
Hawaiian Electric Industries
HE
$2.23B
| $13M | ﹤0.01% |
355,979
-302,827
| -46% | -$11.2M |
|
2144
Canadian Solar
CSIQ
$1.02B
| $13M | ﹤0.01% |
908,911
+335,830
| +59% | +$5.06M |
|
|
2145
PUT
American International
AIG
$41.7B
| $13M | ﹤0.01% |
330,600
-79,500
| -19% | -$3.47M |
|
|
FBM
2146
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $13M | ﹤0.01% |
1,566,258
-10,944
| -0.7% | -$109K |
|
2147
Fomento Económico Mexicano
FMX
$43.6B
| $13M | ﹤0.01% |
150,847
-45,308
| -23% | -$4.02M |
|
2148
Boise Cascade
BCC
$2.69B
| $12.9M | ﹤0.01% |
542,802
-3,982
| -0.7% | -$114K |
|
2149
Travere Therapeutics
TVTX
$5.2B
| $12.9M | ﹤0.01% |
571,370
-111,046
| -16% | -$2.76M |
|
|
TTOO
2150
DELISTED
T2 Biosystems, Inc
TTOO
| $12.9M | ﹤0.01% |
858
| – | – |
|
Similar funds
Goldman Sachs's Q4 2018 Portfolio in Review
As of Q4 2018, Goldman Sachs held 6,043 positions worth $314B, down 19% from $387B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs withdrew a net $17.9B in Q4 2018, closing 848 positions and reducing 2,254 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.64B position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Linde worth $335M.
- Goldman Sachs's largest Q4 2018 buy was Linde: 2,149,240 shares worth $335M.
- Goldman Sachs added most to Energy Transfer Partners in Q4 2018, an estimated $1.35B increase.
- Goldman Sachs's biggest Q4 2018 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $719M.
- Goldman Sachs fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.64B.
- Goldman Sachs's ten largest holdings make up 14% of its $314B portfolio in Q4 2018.
- Goldman Sachs opened 484 new positions and closed 848 in Q4 2018.
- Goldman Sachs's portfolio value fell 19% quarter-over-quarter to $314B.
Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.